Publications by authors named "J Fenemore"

Purpose: Electronic patient-reported outcome measures (ePROMs) are digitalized health questionnaires used to gauge patients' subjective experience of health and disease. They are becoming prevalent in cancer care and have been linked to a host of benefits including improved survival. MyChristie-MyHealth is the ePROM established at the Christie NHS Foundation Trust in 2019.

View Article and Find Full Text PDF

This survey aims to understand the current UK practice for non-small cell lung carcinoma (NSCLC) and identify barriers that may impact patient treatment and outcomes. In March-June 2021, 57 interviews were conducted with healthcare professionals involved in the secondary care management of patients with NSCLC. Most respondents performed genetic testing at onsite and non-genomic laboratory hub (GLH) offsite locations.

View Article and Find Full Text PDF

Purpose: Concurrent chemotherapy and radiotherapy treatment (CCRT) is used to treat locally advanced Non-Small Cell Lung Cancer (NSCLC) in patients with suitable fitness. CCRT is associated with significant toxicity and time spent receiving treatment. Our aim was to identify the support and information needs of patients, and where possible their informal caregivers (IC), at key points along the CCRT pathway.

View Article and Find Full Text PDF

Background: Cancer and its treatment can have significant impacts on health status, quality of life and functioning of patients. Direct information from patients regarding these aspects can be collected via electronic platforms in the form of electronic Patient Reported Outcome Measures (ePROMs). Research has shown that the use of ePROMS in cancer care leads to improved communication, better symptom control, prolonged survival and a reduction in hospital admissions and emergency department attendance.

View Article and Find Full Text PDF
Article Synopsis
  • The Christie NHS Foundation Trust launched an electronic patient-reported outcome measures (ePROMs) service for lung cancer patients in January 2019, enabling them to report symptoms and quality of life (QoL) online.
  • Over 1,400 patients participated, with results showing significant differences in symptoms related to ECOG performance status and comorbidity scores, but no notable differences among age groups.
  • Patients receiving palliative treatment reported improvements in cough and hemoptysis, though mobility declined; those undergoing radical thoracic radiotherapy experienced better hemoptysis but worse pain and fatigue.
View Article and Find Full Text PDF